Zaur Gasimov
A5066424245- Cardiovascular Issues in Pregnancy
- Congenital Heart Disease Studies
- Cardiac Structural Anomalies and Repair
- Health and Lifestyle Studies
- Cardiac pacing and defibrillation studies
- Eicosanoids and Hypertension Pharmacology
- Receptor Mechanisms and Signaling
- Pharmacogenetics and Drug Metabolism
- Heart rate and cardiovascular health
Background In the past 3 decades, arterial switch procedure has replaced atrial as treatment of choice for transposition great arteries. Although survival is superior after procedure, data on pregnancy outcomes are scarce and arteries not yet included in modified World Health Organization classification maternal cardiovascular risk. Methods Results The ROPAC (Registry Pregnancy Cardiac disease) an international prospective registry pregnant women with cardiac disease, part European Society...
Abstract Background Maternal congenital heart disease (CHD) is the most common cardiac condition to complicate pregnancy and women now become pregnant even with complex CHD. The Registry Of Pregnancy And Cardiac (ROPAC) examines relationship between maternal outcome. Methods ESC EORP ROPAC a worldwide prospective registry of pregnancies in structural (n=5739, recruiting 2007-2018), including fetal outcomes were examined all Multivariable regression was used identify associations composite...
ARNI-drug, which consists of two components: the blocker angiotensin receptors -valsartan and neprilysin inhibitor-sacubitril. As a rule, drugs available in cardiological practice, both two-component fixed 3 or more component, consist combination that are successfully used as monotherapy. Examples include calcium antagonists, β-blockers, hydrochlorothiazide, indapamide, valsartan, perindopril, etc. All these have been for many years monotherapy, nowadays, monotherapy combinations.But...
Objective: The aim of our study was to reveal possible specific contribution ivabradine induced heart rate reduction (HRR) mortality in patients with CAD. Design and method: Results from 3 studies relatively similar population medications were used for comparison. Results: SIGNIFY study-Patients(pts) CCS class II or higher angina (n = 12.049),on – 6.037,on placebo 6012pts. All cause death (ACD), cardiovascular (CVD),coronary (CD) pts on vs (325 (5,4%) 288 (4,8%); 245 (4,1%) 210 (3,5%); 199...
Objectives: To reveal CVD risk factors in womens cohort with physical occupational activity (weavers) and compare these findings to the of women intellectual (teachers). Methods: 136 weavers age 42 ± 2, represented a sample 510 working at Baku Weaving Factory (BWF). same 667 teachers State Pedagogical University (SPU). Questionnaires for cardiovascular (interview), anthropometric measures, sitting blood pressure (BP),body mass index (BMI),ECG, fasting samples cholesterol glucose measurements...